Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy

Clinical trial NCT03179631 · COMPLETED

Trial details

NCT number: NCT03179631
Sponsor: PTC Therapeutics
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Muscular Dystrophy, Duchenne Muscular Dystrophies Muscular Disorders, Atrophic Muscular Diseases Musculoskeletal Disease Neuromuscular Diseases Nervous System Diseases Genetic Diseases, X-Linked Genetic Diseases, Inborn

Start date: 2017-07-06
Primary completion: 2022-03-05
Enrollment: 360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.